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Locus Coeruleus and Development of Wake Behavior

Developmental Emergence of Power-Law Wake Behavior Depends Upon the
Functional Integrity of the Locus Coeruleus
Andrew J. Gall, MA1; Badal Joshi, MS2; Janet Best, PhD2; Virginia R. Florang, BA3; Jonathan A. Doorn, PhD3; Mark S. Blumberg, PhD1
Department of Psychology and Delta Center, University of Iowa, Iowa City, IA; 2Department of Mathematics and Mathematical Biosciences
Institute, The Ohio State University, Columbus, OH; 3Division of Medicinal and Natural Products Chemistry, University of Iowa College of
Pharmacy, Iowa City, IA
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Study Objectives: Daily amounts of sleep and wakefulness are accumulated in discrete bouts that exhibit distinct statistical properties. In
adult mammals, sleep bout durations follow an exponential distribution
whereas wake bout durations follow a power-law distribution. In infant
Norway rats, however, wake bouts initially follow an exponential distribution and only transition to a power-law distribution beginning around
postnatal day 15 (P15). Here we test the hypothesis that the locus coeruleus (LC), one of several wake-active nuclei in the brainstem, contributes to this developmental transition.
Design: At P7, rats were injected subcutaneously with saline or DSP4, a neurotoxin that targets noradrenergic (NA) LC terminals. Then, at
P21, sleep and wakefulness during the day and night were monitored.
The effectiveness of DSP-4 treatment was verified by measuring NA,
dopamine (DA), and serotonin (5-HT) concentration in cortical and noncortical tissue using high performance liquid chromatography.
Results: In relation to controls, subjects treated with DSP-4 exhibited
significant reductions only in cortical and non-cortical NA concentration.

Consistent with our hypothesis, the wake bout durations of DSP-4 subjects more closely followed an exponential distribution, whereas those
of control subjects followed the expected power-law distribution. Sleep
bout distributions were unaffected by DSP-4.
Conclusions: These results suggest that the fundamental developmental transition in the statistical structure of wake bout durations is effected in part by changes in noradrenergic LC functioning. Considered
within the domain of network theory, the hub-like connectivity of the LC
may have important implications for the maintenance of network function in the face of random or targeted neural degeneration.
Keywords: Wakefulness, DSP-4, power-law, noradrenaline, locus coeruleus, rat, development, circadian rhythms
Citation: Gall AJ; Joshi B; Best J; Florang VR; Doorn JA; Blumberg MS.
Developmental emergence of power-law wake behavior depends upon
the functional integrity of the locus coeruleus. SLEEP 2009;32(7):920926.

IN HUMANS,1 RATS,2 AND MICE,3 NEWBORNS CYCLE
RAPIDLY BETWEEN SLEEP AND WAKEFULNESS. ONE OF
THE DEFINING FEATURES OF EARLY SLEEP-WAKE development is the consolidation of individual sleep and wake bouts,
as well as the circadian entrainment of the sleep-wake rhythm.4
In addition, analyses of the statistical distributions of sleep and
wake bouts have indicated dramatic changes in the dynamics of
sleep-wake activity. Specifically, whereas sleep bout durations
distribute exponentially in infant5 and adult6,7 mammals, wake
bout durations distribute exponentially during the early postnatal
period and then transition to a power-law distribution that, in rats,
occurs around the time of eye opening at postnatal day (P)15.8
Several factors may account for the developmental transition
from exponential to power-law wake behavior. For example,
because the transition occurs around the time of eye opening,
it is possible that some aspect of visual stimulation is involved.
However, bilateral enucleation at P3 or P11 does not prevent
the normal emergence of power-law wake behavior.4 Alternatively, it is possible that orexinergic neurons, localized in the
lateral hypothalamic nucleus (LHA) and dorsomedial hypothalamic nucleus (DMH), contribute to the emergence of powerlaw wake behavior by activating wake-active monoaminergic

and cholinergic neurons in the brainstem.9-11 However, powerlaw wake behavior emerges in orexin knockout mice just as it
does in wild-types.3 A third possibility, examined here, is that
functional changes in locus coeruleus (LC) activity contribute
to the development of power-law wake behavior.
The LC is a major source of noradrenaline (NA) in the central nervous system and plays an important role in arousal. In
adult rats, activity levels of LC neurons increase during wakefulness, decrease their firing rate during quiet sleep, and are
nearly silent during active sleep12,13; state-related changes in LC
activity are detectable as early as P8 in rats.14 Increased discharge rates of LC neurons are associated with spontaneous or
sensory-evoked interruptions of sleep.12,15 Finally, stimulation
of LC activity promotes wakefulness,16,17 whereas inhibition of
LC activity promotes sleep.18
To test the hypothesis that the LC contributes to the developmental emergence of power-law wake behavior, we administered
N-(2-choloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), a
neurotoxin that selectively destroys noradrenergic LC terminals
in infant19 and adult20-23 rats. In the present study, DSP-4 was administered to P7 rats and we examined their sleep-wake behavior
2 weeks later, at P21. We predicted that interfering with LC function in early infancy would prevent or dampen the developmental
transition from exponential to power-law wake behavior.
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Methods
All experiments were performed in accordance with National Institutes of Health guidelines for the care of animals in
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research and were approved by the Institutional Animal Care
and Use Committee of the University of Iowa. All efforts were
made to minimize the number of animals used.

During the day, data were acquired from 11:00 to 16:00. At
night, the 2 remaining same-sex littermates were implanted
with EMG electrodes (again, under red light illumination) and
tested identically to those during the day, with data being acquired from 23:00 to 04:00. The order of daytime and nighttime
tests was counterbalanced across litters.

Subjects
Thirty-two Sprague-Dawley rats from 8 litters were used.
Males and females were equally represented and littermates
were always assigned to different experimental groups. Litters
were culled to 8 pups within 3 days of birth (day of birth = P0).
Mothers and their litters were housed and raised in standard
laboratory cages (48 × 20 × 26 cm) in the animal colony at the
University of Iowa. Food and water were available ad libitum.
All animals were maintained on a 12-h light-dark schedule with
lights on at 07:00.

HPLC Analysis of Noradrenaline (NA), Dopamine (DA), and
Serotonin (5-HT) Concentrations
No more than 2 days after testing, each pup was anesthetized
with isoflurane and decapitated. The brain was removed rapidly
and placed on ice. The cerebral cortex was quickly dissected
out, placed in 15 mL Sarstedt polypropylene tubes, and frozen
in liquid nitrogen. Samples were stored at −80˚C until homogenization. The cerebral cortex of each rat was homogenized in
0.1 Normal (N) perchloric acid. Homogenate was centrifuged
at 17,300 g for 10 min at 4°C. The clear supernatant was filtered
through a 0.22 µm Millex-GP filter unit (Millipore, Bedford,
MA) and analyzed for levels of NA. Analysis was performed
using a Waters 2690 HPLC (Milford, MA) equipped with an
ESA Coulochem III (Chemford, MA) with E1 and E2 potentials
set to -150 mV and 200 mV, respectively. Eight µL of sample
diluted 1:4 with water were injected into a Synergi Hydro 4
µm reversed phase column (Phenomenex, Torrance, CA) with a
mobile phase containing 75 mM phosphoric acid, 25 mM citric
acid, 1.8 mM sodium dodecyl sulfate, and 2% acetonitrile adjusted to pH 3.0.
A follow-up experiment was performed using 12 additional
subjects from 6 litters. From each litter, 2 P7 littermates were
injected with DSP-4 or saline as described earlier. At P21, the
brain was removed, placed on ice, and the cortex was dissected
out for analysis. In addition, the remaining brain tissue (including medulla, midbrain, and diencephalon, minus the cerebellum) was also saved. These cortical and non-cortical samples
were prepared for HPLC analysis of NA, DA, and 5-HT concentrations. (These animals were not tested for sleep and wakefulness.) Samples were analyzed using an Agilent 1100 HPLC
system (Santa Clara, CA) and an ESA Coulochem III electrochemical detector (settings as previously described). Separation was achieved by injecting 20 µL of undiluted sample
onto a Thermo Aquasil C18 5 µm 150 × 2.1 mm column. DA
and 5-HT were analyzed by an isocratic method using mobile
phase containing 0.1% trifluoroacetic acid (TFA), 50 mM citric
acid, 1% methanol, and 1% acetonitrile adjusted to pH 3.0. NA
analysis was carried out using a gradient program; the aqueous
phase contained 0.2% trifluoroacetic acid, 50 mM citric acid,
and 2 mM sodium heptane sulfonate pH 3.0, and the organic
phase contained acetonitrile 3% to 18% (3% at 0–8 minutes,
linearly increasing to 18% by 19 minutes, and returning to 3%
at 20 minutes).

DSP-4 Treatment
At P7, 4 same-sex litter mates were chosen as experimental
subjects. Two of these pups were injected subcutaneously with
50 mg/kg of DSP-4 (Sigma, St. Louis, MO), and 2 control pups
were injected with saline. Pups were then tattooed and placed
back in the litter for testing 2 weeks later. The same procedure
was used for the remaining 7 litters.
Surgery
On the day of testing at P21-22 (hereafter referred to as P21),
2 same-sex littermates, 1 previously injected with DSP-4 and 1
with saline, were implanted with nuchal EMG electrodes. Under isoflurane anesthesia, 2 bipolar stainless steel electrodes (50
µm diameter, California Fine Wire, Grover Beach, CA) were
inserted bilaterally into the nuchal muscles and secured with
flexible collodion.24 After surgery, pups recovered in a humidified test chamber maintained at thermoneutrality. All surgeries
took place at least 2 h before testing. For testing at night, surgery was performed under dim red light illumination, with care
being taken to ensure that infants were not exposed to white
light. After surgery, each pup was transferred to an individual
test chamber maintained at thermoneutrality (i.e., 32°C) where
it recovered and acclimated for at least 2 h before testing.
Test Procedure
DSP-4 and saline control subjects were tested simultaneously
but separately in two electrically shielded double-walled glass
chambers (height, 18 cm; i.d., 12 cm). Air temperature inside
each chamber was maintained at thermoneutrality by regulating
the temperature of the water that circulated through the walls
of the chamber. Compressed, humidified air passed through the
sealed chamber at the rate of 300 mL/min. A round platform
constructed of polyethylene mesh was fitted inside each chamber, which allowed the pup to move freely on the platform’s
surface.
The nuchal electrodes were connected to differential amplifiers (A-M systems, Carlsborg, WA) and their signals were
amplified (×10 k) and filtered (300–5000 Hz). EMG data were
acquired (1000 samples/s) and stored using a data acquisition
system (Biopac Systems, Santa Barbara, CA).
SLEEP, Vol. 32, No. 7, 2009

Data Analysis
For all subjects, EMG data were analyzed off-line using AcqKnowledge software (Biopac Systems, Santa Barbara, CA).
The EMG signal was integrated and full-wave rectified, and
then dichotomized into periods of high muscle tone and atonia
(or wakefulness and sleep, respectively), as described earlier.2
921
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Table 1—Sleep and Wake Bout Durations, Percentage of Time Awake, and Number of Sleep-Wake Cycles per Hour in P21 Rats Treated on
P7 with DSP-4 or Saline
Group
Sleep bout duration (s)
Wake bout duration (s)
Mean % of
		
Mean
Median
Mean
Median
time awake
DSP-4						
Day
82.5 (8.2)
53.6 (7.4)a
40.9 (5.6)b
17.3 (2.7)b
33.3 (4.3)a,b
b
b
Night
73.4 (8.6)
32.9 (6.2)
55.2 (10.7)
25.5 (7.2)
41.4 (4.1)b
Saline						
Day
89.2 (7.0)
62.3 (6.9)a
25.4 (3.2)
6.5 (0.7)
21.9 (1.6)a
Night
79.8 (6.0)
48.0 (6.3)
35.7 (3.3)
7.1 (0.5)
30.8 (1.9)

Mean no. of
sleep-wake
cycles per h
30.4 (2.4)
31.6 (4.5)
33.2 (3.8)
32.1 (2.3)

Standard Errors are in Parentheses. asignificant main effect of test time (i.e., day vs. night). bsignificant main effect of group (i.e., DSP-4 vs. saline)

An experienced individual blind to experimental condition
scored the data. It should be stressed that EMG measures alone
allow for accurate measurement of sleep and wake durations
in infant rats before, during, and after the emergence of delta
activity.25 Moreover, the statistical structures of sleep and wake
bouts derived from EMG measures at P21 in rats8 and mice3
resemble those derived in adults using additional electrographic
measures.7
Sleep and wake bout durations were imported into Statview
5.0 (SAS Institute, Cary, NC) for analysis. Mean and median
bout durations were determined for each subject and mean values were calculated across subjects. Mean percentage of time
awake was calculated by dividing the mean wake bout duration
by the sum of the mean sleep and wake bout durations, and
multiplying by 100. The mean number of sleep-wake cycles
per hour was also calculated. Two-factor analysis of variance
(ANOVA) was used to test for differences across groups (i.e.,
DSP-4 vs. saline control) and test times (i.e., day vs. night).
NA, DA, and 5-HT concentrations were expressed as ng/mL
tissue homogenate and reported as percentage change in DSP-4
subjects in relation to paired saline controls. Paired t tests were
used to test group differences.
As described elsewhere,8 log-survivor distributions of sleep
and wake bouts were produced from individual and pooled data.
For each subject, least-squares estimates (r2) were calculated to
assess the degree of fit to exponential and power-law distributions. Two-factor ANOVAs, performed separately for the day
and night, were used to test for differences across group (i.e.,
DSP-4 vs. saline control) and distribution (i.e., power-law vs.
exponential). Paired t tests were used for planned comparisons
to assess within-group differences in r2.
For these tests, α was set at 0.05. Means are presented with
their standard errors.
We used a second analytic technique to test whether bout
duration data provided more evidence for a power-law or exponential model. Specifically, using pooled data, log-likelihood
functions were calculated and maximized for each model.26-28
The comparison was quantified by calculating the Akaike
weights, wi (i = 1,2), for each model: wi = exp(-∆i/2)/(exp(-∆1/2)
+ exp(-∆2/2)). Here, ∆i is a measure of each model relative to
the better model; ∆i = 0 for the model with larger log-likelihood
value. For the other model, ∆i > 0 is calculated as the difference
of Akaike Information Criterion (AIC) values, AICi = −2(loglikelihoodi) +2ki, where ki is the number of parameters in model
i. (Note that the sum of the Akaike weights equals 1). The AkaiSLEEP, Vol. 32, No. 7, 2009

ke weight for a model estimates the probability that the model
is the better of the 2 candidate models.26,29 The Akaike weights
are useful for model comparison. They give the probability of a
certain model being a better fit among all the chosen candidate
models. Therefore, the model with a weight of 1 is a better fit
than the model with a weight of 0. It should be emphasized,
however, that this criterion cannot tell us if the best-fit model
is indeed a good fit. For goodness of fit, we use the more traditional approach.
Results
Table 1 shows that mean sleep bout durations were not
significantly affected by DSP-4 treatment during the day or
night (group: F1,28 = 0.7; test time: F1,28 = 1.5; group × time
interaction: F1,28 = 0.0); median sleep bout durations were significantly longer during the day (F1,28 = 6.9, P < 0.05); there
was no main effect of group (F1,28 = 3.2) and no group × time
interaction (F1,28 = 0.2). Both mean and median wake bout durations were significantly longer in DSP-4 subjects (F1,28s >
7.3, P < 0.05); there were no main effects of time (F1,28s < 3.6)
and no group × time interactions (F1,28s < 1.0). Similarly, mean
percentage time awake was significantly longer for DSP-4
subjects than saline controls (F1,28 = 11.8, P < 0.005), and was
significantly greater at night than during the day (F1,28 = 7.0,
P < 0.05); the interaction was not significant (F1,28 = 0.0). Finally, the number of sleep-wake cycles per hour was not affected by DSP-4 treatment (group: F1,28 = 0.2; time: F1,28 = 0.0;
interaction: F1,28 = 0.1).
Figure 1 presents pooled log-survivor distributions for P21
subjects treated at P7 with DSP-4 or saline. Sleep bout durations for both the DSP-4 and saline control P21 subjects during
the day and night fall along a straight line, indicative of an exponential distribution (Fig. 1A). As predicted, wake bout durations for DSP-4 subjects more closely followed an exponential
distribution during the day and night (Fig. 1B); in contrast, the
wake bout durations for the saline control subjects followed a
power-law distribution.
As shown in Figure 2A, sleep bout durations were always
better fit by an exponential than a power-law distribution. ANOVAs performed separately for the day and night revealed significant main effects of distribution (F1,28s > 139.5, Ps < 0.0001),
but there were no main effects of group (F1,28s < 2.1). Also, the
group × distribution interaction was significant at night (F1,28 =
6.8, P < 0.05) but not during the day (F1,28 = 2.6).
922
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Figure 1—Log-survivor plots of sleep (A) and wake (B) bout durations in P21 rats treated with DSP-4 or saline. Each semi-log
plot was constructed using pooled data (677-1180 data points).
Straight lines on these plots indicate that the data follow an exponential distribution.

Table 2—Mean Percentage Change in Cortical and Non-Cortical
Noradrenaline (NA), Dopamine (DA), and Serotonin (5-HT) in
P21 Rats Treated on P7 with DSP-4 in Relation to Saline Controls

Figure 2—Values of r2 using regression analysis of sleep (A) and
wake (B) bout durations in DSP-4 and saline control P21 subjects.
Sleep bout durations are better fit by exponential distributions
during the day and night in subjects treated with DSP-4 or saline.
Wake bout durations are better fit by power-law distributions in
saline control subjects during the day and night. In contrast, wake
bout durations in DSP-4 subjects are fit better by neither a powerlaw nor exponential distribution during the day, but are better fit
by an exponential distribution at night. *significant difference between exponential and power-law fits.

NA
DA
5-HT
Cortical tissue
−80.7 (4.2)* −13.3 (23.0) +4.5 (16.0)
Non-cortical tissue
(excluding cerebellum) −73.9 (7.8)* −4.7 (37.1) +23.6 (25.6)
Standard errors are in parentheses. *significant difference from 0%

Figure 2B shows, as expected,8 that wake bout durations for
saline control subjects during the day and night were better fit
by a power-law distribution. In contrast, for DSP-4 subjects at
night, the better fit was to an exponential distribution. For DSP4 subjects during the day, the fit to a power-law distribution was
clearly reduced, although the fit to an exponential distribution
was not increased. ANOVAs revealed a significant main effect
of distribution during the day (F1,28 = 16.4, P < 0.0005) but not
at night (F1,28 = 1.4). There were no main effects of group during the day or night (F1,28s < 3.2), but the group × distribution
interactions were significant (F1,28s > 11.6, Ps < 0.005).
As expected, analyses of pooled and individual Akaike
weights indicated that sleep bout durations were better fit by
an exponential model in both saline control and DSP-4 subjects
during the day and night (Akaike weights equal to 1). Also as
expected, wake bout durations for saline control subjects were
better fit by a power-law model during both the day and night
(Akaike weights equal to 1). In contrast, wake bout durations
for DSP-4 subjects were better fit by an exponential model during both the day and night (Akaike weights equal to 1), thus
providing even stronger support for the finding, presented in
SLEEP, Vol. 32, No. 7, 2009

Figure 2B, that DSP-4 treatment suppresses the expression of
power-law wake behavior at P21.
A follow-up analysis of individual data indicated that 2 DSP4 subjects exhibited differences from the pooled results. Specifically, one DSP-4 subject’s wake bout durations were better
fit by a power-law model (Akaike weight equal to 1), and the
other DSP-4 subject’s wake bout durations distributed poorly to
both exponential and power-law models.
Finally, to provide additional information regarding the effect of DSP-4 treatment on NA, DA, and 5-HT concentrations
in cortical and non-cortical tissue, 12 additional subjects from 6
litters were tested identically to the initial set of subjects (with
the exception that sleep-wake activity was not monitored). As
shown in Table 2, animals treated with DSP-4 at P7 exhibited
significant reductions at P21 in both cortical (t21 = 19.2, P <
0.0001) and non-cortical (t5 = 9.5, P < 0.0005) NA concentration in relation to saline controls. Importantly, and as expected,19
DSP-4 subjects did not exhibit significant changes in cortical
or non-cortical DA or 5-HT concentration in relation to saline
controls (t5s > 0.1, NS).
923
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Discussion

and these effects persist into adulthood.19 Thus, we chose to inject rats with DSP-4 at P7 and test them 2 weeks later with the
expectation that NA would be depleted in any brain region to
which the LC projects. In other words, NA concentration was
used as a bioassay of the efficacy of the DSP-4 treatment. Our
findings that DA and 5-HT concentrations were unaffected by
DSP-4 treatment support previous findings that DSP-4 selectively reduces NA concentration in the brain.19
The expression of sleep and wakefulness throughout the day
and night reflect the variable influences of circadian and homeostatic mechanisms.39 However, sleep and wake durations
accumulate one bout at a time, and we now know that these
individual bouts follow discernible statistical rules.4,6-8 These
rules, in turn, reflect the dynamic interactions among hypothalamic and brainstem nuclei involved in the expression of ultradian sleep-wake cycles.
Wake bouts follow a power-law distribution in humans, cats,
and rats,7,8,40 and wild-type and orexin knockout mice.3,7,36 This
power-law structure (in which a small percentage wake bouts is
considerably longer than most other wake bouts) may contribute to the efficient partitioning and budgeting of wake-related
activities. Specifically, this power-law property may reflect the
value for an animal of continuous and lengthy periods of wakefulness.
Among mathematical biologists, the significance of powerlaw distributions and the mechanisms that give rise to them are
topics of vigorous discussion.41,42 In the present context, it is
worth considering that a power-law distribution is the signature
of so-called scale-free networks comprising centralized hubs
from which a disproportionate number of connections to other
nodes in the network is made.43 In this regard, the neural system that produces wakefulness may be viewed as a complex
network comprising a collection of hubs with varying degrees
of connectivity.41,44 Interestingly, LC neurons differentiate very
early in development45 and soon give rise to a complex network
of dense connections that project widely throughout the central
nervous system, including the cerebral cortex, hippocampus,
thalamus, midbrain, brainstem, cerebellum, and spinal cord.46-49
The LC also receives dense projections from glutamatergic,
GABAergic, orexinergic, serotonergic, and noradrenergic neurons, among others.47 Accordingly, the LC, with its dense efferent and afferent projections, qualifies as a highly connected
hub.
An interesting property of scale-free networks is that they
are more robust (i.e., more resistant to failure) than are random
networks50 in the face of random damage to the network. On the
other hand, scale-free networks are more vulnerable to failure
when damage comes in the form of an attack targeted at a hub.
Thus, we hypothesize that the neural circuitry underlying the
power-law structure of wake bouts has evolved in part because
of its enhanced robustness in the face of random attack and that
the use here of DSP-4 can be considered a “targeted” (i.e., nonrandom) attack on the LC. If so, then it follows that the sleep
system may be more sensitive than the wake system to random neuronal loss (e.g., as appears to occur during aging51,52),
perhaps providing an explanation for the relative prevalence of
sleep-related disorders such as insomnia.53 We caution, however, that the convincing application of network theory to sleepwake organization will depend in part on the development of a

The locus coeruleus is a major source of noradrenaline in the
central nervous system that mediates spontaneous and evoked
arousals.12,15 Here we used the neurotoxin DSP-4 to destroy NA
terminals from the LC in order to assess the contributions of
this structure to sleep and wake bout durations in P21 rats. We
found no significant effect of DSP-4 on sleep bout durations,
but wake bout durations were significantly increased, as was
the percentage of time awake.
As expected, sleep bout durations uniformly followed exponential distributions that were unaffected by treatment with
DSP-4. In contrast, whereas wake bout durations in saline control subjects were better fit by a power-law distribution, wake
bout durations of DSP-4 subjects were better fit by an exponential distribution, as is the case in untreated younger rats.4,8 These
conclusions were supported using 2 analytic procedures: leastsquares (r2) and maximum likelihood estimation.26,28,29 Thus, it
appears that developmental changes in LC function contribute
to the development of power-law wake behavior during the
third postnatal week.
Previous studies have examined the role of DSP-4 on sleep
and wakefulness in adults using conventional measures (e.g.,
mean, median, total sleep and wake durations); these studies
have yielded variable and inconsistent results.20,30-33 In these
studies, sleep and wake bout distributions were not analyzed,
thus making it difficult to make direct comparisons between
the results found in these earlier studies and those found here.
Importantly, the current study is unique in that DSP-4 was injected in early infancy—in particular, before the development
of power-law wake behavior. Thus, the timing of DSP-4 administration may critically determine its effects on wake bout
distributions. It is also possible that analyses of sleep and wake
bout distributions, rather than mere assessments of cumulative
sleep and wake durations, provide a more reliable and sensitive
indicator of sleep-wake dynamics and their underlying neural
control.8,34
It has been suggested that arousal is maintained, at least in
part, by an SCN-DMH-LC wake-active circuit.35 Orexinergic
neurons within the DMH have been hypothesized to be critically involved in the maintenance of arousal35 and provide dense
projections to the LC.11 However, power-law wake behavior develops normally in orexin knockout mice3 and is expressed in
adult mice.36 Thus, to the extent that the SCN-DMH-LC circuit
is critically involved in arousal, it is possible that non-orexinergic afferents to the LC, possibly from the DMH or elsewhere,35
contribute to the development of power-law wake behavior in
infant rats and mice. In addition, because the LC exerts inhibitory influences on the sleep-promoting ventrolateral preoptic
area (VLPO),37 it is possible that DSP-4 diminished this inhibitory influence, thereby altering the reciprocal interactions
among LC, VLPO, and other nuclei involved in the regulation
of sleep and wakefulness.38
The effects of DSP-4 treatment on NA in specific brain areas
depend upon the age at which DSP-4 is administered and the
interval between DSP-4 administration and NA measurement.19
Using similar methods to those used here, DSP-4 treatment (50
mg/kg) in week-old rats selectively and rapidly (i.e., within 1
day) depletes NA in cerebral cortex, brainstem, and spinal cord,
SLEEP, Vol. 32, No. 7, 2009
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process model of network behavior that can produce phenomena akin to sleep and wake bouts.41
The present results highlight how a structure like the LC exerts a subtle and complex influence that can be overlooked if
sufficiently sensitive measures of sleep-wake cyclicity are not
used. Thus, while we agree that the LC is likely more than simply a wake-active nucleus that modulates arousal,54 even our understanding of the role of the LC in the regulation of arousal is
incomplete. We suggest that the LC comprises one component
of a system that serves to modify the temporal structure of wake
bouts such that prolonged periods of spontaneous wakefulness
are possible. Given that this modification occurs in rats at the
beginning of the third postnatal week, the LC and its associated
structures may make it possible for the developing infant to engage more effectively with its environment at a time of increasing independence from its mother and littermates.
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